Vaughan LM - Search Results

1

Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.

Vaughan LM, Milavetz G, Weinberger MM, Smith GD, Harris JB. Vaughan LM, et al. Ther Drug Monit. 1988;10(4):395-400. doi: 10.1097/00007691-198804000-00005. Ther Drug Monit. 1988. PMID: 3059587 Clinical Trial.

2

Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children.

Vaughan LM, Milavetz G, Weinberger MM, Smith GD, Merrick JG. Vaughan LM, et al. Drug Intell Clin Pharm. 1988 Sep;22(9):684-7. doi: 10.1177/106002808802200906. Drug Intell Clin Pharm. 1988. PMID: 3215109

3

Relationship between rate and extent of absorption of oral theophylline from Uniphyl brand of slow-release theophylline and resulting serum concentrations during multiple dosing.

Milavetz G, Vaughan LM, Weinberger MM, Harris JB, Mullenix TA. Milavetz G, et al. Among authors: vaughan lm. J Allergy Clin Immunol. 1987 Nov;80(5):723-9. doi: 10.1016/0091-6749(87)90294-6. J Allergy Clin Immunol. 1987. PMID: 3680816 Clinical Trial.

4

Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity.

Hendeles L, Weinberger M, Milavetz G, Hill M 3rd, Vaughan L. Hendeles L, et al. Chest. 1985 Jun;87(6):758-65. doi: 10.1378/chest.87.6.758. Chest. 1985. PMID: 3996063

5

Dose dependency for absorption and elimination rates of theophylline. Implications for studies of bioavailability.

Milavetz G, Weinberger M, Vaughan L. Milavetz G, et al. Pharmacotherapy. 1984 Jul-Aug;4(4):216-20. doi: 10.1002/j.1875-9114.1984.tb03361.x. Pharmacotherapy. 1984. PMID: 6483638

6

Influence of gender on theophylline dosage requirements in children with chronic asthma.

Hendeles L, Vaughan L, Weinberger M, Smith G. Hendeles L, et al. Drug Intell Clin Pharm. 1981 May;15(5):338-40. doi: 10.1177/106002808101500504. Drug Intell Clin Pharm. 1981. PMID: 7274049 No abstract available.

7

Comparative efficiency of a laboratory and examining room assay for therapeutic drug monitoring of theophylline in ambulatory patients.

Milavetz G, Vaughan LM, Weinberger MM. Milavetz G, et al. Among authors: vaughan lm. Ann Allergy. 1989 May;62(5):453-6. Ann Allergy. 1989. PMID: 2719355

8

Stability of theophylline elimination rate.

Milavetz G, Vaughan LM, Weinberger MM. Milavetz G, et al. Among authors: vaughan lm. Clin Pharmacol Ther. 1987 Apr;41(4):388-91. doi: 10.1038/clpt.1987.46. Clin Pharmacol Ther. 1987. PMID: 3549119

9

Evaluation of a scheme for establishing and maintaining dosage of theophylline in ambulatory patients with chronic asthma.

Milavetz G, Vaughan LM, Weinberger MM, Hendeles L. Milavetz G, et al. Among authors: vaughan lm. J Pediatr. 1986 Aug;109(2):351-4. doi: 10.1016/s0022-3476(86)80403-6. J Pediatr. 1986. PMID: 3734974

10

A bioassay for topical and systemic effect of three inhaled corticosteroids.

McCubbin MM, Milavetz G, Grandgeorge S, Weinberger M, Ahrens R, Sargent C, Vaughan LM. McCubbin MM, et al. Among authors: vaughan lm. Clin Pharmacol Ther. 1995 Apr;57(4):455-60. doi: 10.1016/0009-9236(95)90216-3. Clin Pharmacol Ther. 1995. PMID: 7712675 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page